Practice parameters for the treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder

Sleep

Volumn 22, Issue 7, 1999, Pages 961-968

  Chesson Jr , Andrew L ^a   Wise, Merrill ^b   Davila, David ^c   Johnson, Stephen ^d   Littner, Michael ^e   McDowell Anderson, W ^f   Hartse, Kristyna ^g   Rafecas, Jose ^h  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Baptist Health Medical Center Little Rock   (United States)

^d Western Montana Clinic   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g SLEEP CONSULTANTS INC   (United States)

^h Ohio Sleep Disorders Center   (United States)

Author keywords

Periodic limb movement disorder; Practice guidelines; Practice parameters; Restless legs syndrome; Sleep disorders; Treatment

Indexed keywords

CARBAMAZEPINE; CARBIDOPA; CLONAZEPAM; CLONIDINE; DEXTROPROPOXYPHENE; GABAPENTIN; LEVODOPA; NARCOTIC ANALGESIC AGENT; PERGOLIDE; PRAMIPEXOLE; TRIAZOLAM;

ARTICLE; ATAXIA; DYSKINESIA; EVIDENCE BASED MEDICINE; HALLUCINATION; HUMAN; INSOMNIA; LIMB MOVEMENT; MOTOR DYSFUNCTION; NAUSEA; PERIODIC LIMB MOVEMENT DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SOMNOLENCE;

EID: 0345440146     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/22.7.961     Document Type: Article

References (33)

1. The International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord, 1995; 10:634-642.
2. American Sleep Disorders Association. International classification of sleep disorders, revised: Diagnostic and coding manual. Rochester, Minnesota: American Sleep Disorders Association, 1997.
3. Montplaisir, J., Boucher, S., Poirier, G., Lavigne, G., Lapierre, O., and Lesperance, P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord, 1997; 12:61-65.
4. Hening, W., Allen, R., Silber, M., Earley, C., Kushida, C., and Picchietti, D. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep, 1999; 22.
5. Ekbom, K.A. Restless legs syndrome. Neurology, 1960; 10:868-873.
6. Montplaisir, J., Godbout, R., Pelletier, G., and Warnes, H. Restless legs syndrome and periodic limb movements during sleep. In: Kryger, M.H., Roth, T., and Dement, W.C., eds. Principles and Practice of Sleep Medicine. Philadelphia: W.S. Saunders Company, 1994:589-597.
7. Chokroverty, S. and Jankovic, J. Restless legs syndrome: a disease in search of identity. Neurology, 1999; 52:907-910.
8. Lazarou, J., Pomeranz, B.H., and Corey, P.N. Incidence of adverse drug reactions in hospitalized patients. JAMA, 1998; 279:1200-1205.
9. Fazzini, E., Diaz, R., and Fahn, S. Restless Leg in Parkinson's Disease - Clinical Evidence for Underactivity of Catecholamine Neurotransmission. Ann Neurol, 1989; 26(1):142.
10. Andersen, S. and Leikersfeldt, G. Management of chronic non-malignant pain. Br J Clin Prac, 1996; 50:324-330.
11. Pappagallo, M. and Heinberg, L.J. Ethical issues in the management of chronic nonmalignant pain. Semin Neurol, 1997; 17:203-211.
12. Merck and Co. and Sinemet, C.R. Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Publishing, 1999:940-943.
13. Athena Neurosciences, Inc. Permax. Physicians'Desk Reference. Montvale, New Jersy: Medical Economics Publishing, 1999:614-617.
14. Pharmacia & Upjohn Company. Mirapex. Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Publishing, 1999a:2497-2501.
15. Reisine, T. and Pasternak, G. Opiod analgesics and antagonists. In: Hardman, J.G. and Limbird, L.E., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw Hill, 1996:521-555.
16. Roche Pharma Inc. Klonopin. Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Publishing, 1999:2688-2691.
17. Pharmacia & Upjohn Company. Halcion. Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Publishing, 1999b:2490-2493.
18. Parke-Davis. Neurontin. Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Publishing, 1999:.
19. Jones, K.L., Lacro, R.V., Johnson, K.A., and Adams, J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. New Engl J Med, 1989; 320:1661-1666.
20. Mattson, R.H., Cramer, J.A., and Collins, J.F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. New Engl J Med, 1992; 327:765-771.
21. Mattson, R.H., Cramer, J.A., Collins, J.F., et al. Comparison of carbamazepine, phenobarbital, phehytoin, and primidone in partial and secondary generalized tonic-clonic seizures. New Engl J Med, 1985; 313:145-151.
22. Hollifield, J. Clinical acceptability of transdermal clonidine: a large scale evaluation by practitioners. Am Heart J, 1986; 112:900-906.
23. Sackett, D. Rules of Evidence and Clinical Recommendation. Can J Cardiol, 1993; 9:487-489.
24. Eddy, D.M., eds. A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach. Philadelphia: American College of Physicians, 1992.
25. Becker, P.M., Ondo, W., and Sharon, D. Encouraging initial response of restless legs syndrome to pramipexole. Neurology, 1998; 51(4):1221-3.
26. Lin, S.C., Kaplan, J., Burger, C.D., and Fredrickson, P.A. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc, 1998; 73(6):497-500.
27. Montplaisir, J., Nicolas, A., Denesle, R., and Gomez-Mancilla, B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology, 1999; 52(5):938-43.
28. Pieta, J., Millar, T., Zacharias, J., Fine, A., and Kryger, M. Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep, 1998; 21(6):617-22.
29. Wetter, T.C., Stiasny, K., Winkelmann, J., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology, 1999; 52(5):944-50.
30. Noel, S., Korri, H., and Vanderheyden, J.E. Low dosage of pergolide in the treatment of restless legs syndrome. Acta Neurol Belg, 1998; 98(1):52-3.
31. Collado-Seidel, V., Kazenwadel, J., Wetter, T.C., et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology, 1999; 52(2):285-90.
32. Merren, M.D. Gabapentin for treatment of pain and tremor: a large case series. South Med J, 1998; 91(8):739-44.
33. Hornyak, M., Voderholzer, U., Hohager, F., Berger, M., and Riemann, D. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep, 1998; 21(5):501-5.